GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | 8/14/2026 8:14:32 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $788,000 -53.4% | Assets $82,068,000 | EPS -$0.34 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/14/2026 8:02:44 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $788,000 -53.4% | Assets $82,068,000 | EPS -$0.34 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/12/2026 8:15:17 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $980,000 -49.4% | Assets $96,562,000 | EPS -$0.34 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/12/2026 8:00:45 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $980,000 -49.4% | Assets $96,562,000 | EPS -$0.34 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 4/22/2026 8:04:23 AM | View | Proxy | SEC | Y 2025 | ||||||
| PMV Pharmaceuticals, Inc. (PMVP) | 3/6/2026 8:25:40 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $1,232,000 -46.1% | Assets $116,562,000 | EPS -$0.34 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 3/6/2026 8:13:28 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $6,337,000 -40.5% | Assets $116,562,000 | EPS -$1.48 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/12/2025 8:14:28 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,480,000 -43.4% | Assets $133,844,000 | EPS -$0.40 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/12/2025 8:01:01 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,480,000 -43.4% | Assets $133,844,000 | EPS -$0.40 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/7/2025 8:12:03 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,690,000 -39.7% | Assets $152,855,000 | EPS -$0.41 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/7/2025 8:01:29 AM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $1,690,000 -39.7% | Assets $152,855,000 | EPS -$0.41 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/9/2025 8:12:42 AM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,935,000 -34.5% | Assets $170,608,000 | EPS -$0.34 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/9/2025 8:01:53 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $1,935,000 -34.5% | Assets $170,608,000 | EPS -$0.34 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 4/25/2025 9:01:36 AM | View | Proxy | SEC | Y 2024 | ||||||
| PMV Pharmaceuticals, Inc. (PMVP) | 3/3/2025 8:56:14 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $10,655,000 -4.6% | Assets $191,288,000 | EPS -$1.14 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 3/3/2025 8:01:33 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $2,287,000 -27.8% | Assets $191,288,000 | EPS -$0.45 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/7/2024 8:11:22 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,615,000 -12.4% | Assets $223,495,000 | EPS -$0.37 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/7/2024 8:01:32 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $2,615,000 -12.4% | Assets $223,495,000 | EPS -$0.37 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/8/2024 8:18:48 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $2,801,000 +3.9% | Assets $237,539,000 | EPS -$0.02 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/8/2024 8:01:40 AM | View | Financials | Earnings | SEC | 2Q 2024 | Rev $2,801,000 +3.9% | Assets $237,539,000 | EPS -$0.02 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/9/2024 8:18:21 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,952,000 +27.0% | Assets $236,876,000 | EPS -$0.30 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/9/2024 8:01:19 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,952,000 +27.0% | Assets $236,876,000 | EPS -$0.30 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 4/24/2024 8:01:27 AM | View | Proxy | SEC | Y 2023 | ||||||
| PMV Pharmaceuticals, Inc. (PMVP) | 2/29/2024 4:41:47 PM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $11,171,000 +208.0% | Assets $252,152,000 | EPS -$1.44 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 2/29/2024 4:08:18 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $3,166,000 +76.2% | Assets $252,152,000 | EPS -$0.31 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/9/2023 8:18:19 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $2,984,000 +165.5% | Assets $261,027,000 | EPS -$0.34 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/9/2023 8:03:11 AM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $2,984,000 +165.5% | Assets $261,027,000 | EPS -$0.34 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/9/2023 8:16:00 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Rev: $2,696,000 +346.4% | Assets $242,216,000 | EPS -$0.38 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/9/2023 8:01:00 AM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $2,696,000 +346.4% | Assets $242,216,000 | EPS -$0.38 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/10/2023 8:13:32 AM | Small | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $2,325,000 +915.3% | Assets $253,960,000 | EPS -$0.42 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/10/2023 8:01:28 AM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $2,325,000 +915.3% | Assets $253,960,000 | EPS -$0.42 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 4/28/2023 8:03:48 AM | View | Proxy | SEC | Y 2022 | ||||||
| PMV Pharmaceuticals, Inc. (PMVP) | 3/1/2023 8:18:49 AM | Small | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $3,627,000 +707.8% | Assets $270,308,000 | EPS -$1.61 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 3/1/2023 8:02:31 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $1,797,000 +1,595.3% | Assets $270,308,000 | EPS -$0.43 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/8/2022 8:18:46 AM | Small | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Rev: $1,124,000 +1,002.0% | Assets $284,984,000 | EPS -$0.40 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/8/2022 8:01:46 AM | View | Financials | Earnings | SEC | 3Q 2022 | Rev $1,124,000 +1,002.0% | Assets $284,984,000 | EPS -$0.40 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/9/2022 8:16:46 AM | Small | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Rev: $604,000 +434.5% | Assets $300,564,000 | EPS -$0.38 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/9/2022 8:02:01 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev $604,000 +434.5% | Assets $300,564,000 | EPS -$0.38 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/10/2022 7:26:39 AM | Small | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Rev: $229,000 +78.9% | Assets $315,008,000 | EPS -$0.41 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/10/2022 7:16:24 AM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $229,000 +78.9% | Assets $315,008,000 | EPS -$0.41 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 4/22/2022 8:02:06 AM | View | Proxy | SEC | Y 2021 | ||||||
| PMV Pharmaceuticals, Inc. (PMVP) | 3/1/2022 7:32:07 AM | Small | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Rev: $449,000 -31.0% | Assets $331,568,000 | EPS -$1.28 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 3/1/2022 7:17:30 AM | View | Financials | Earnings | SEC | Y 2021 | Rev $106,000 +120.8% | Assets $331,568,000 | EPS -$0.40 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/12/2021 7:35:19 AM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Rev: $102,000 +155.0% | Assets $344,178,000 | EPS -$0.33 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/12/2021 7:17:38 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $102,000 +155.0% | Assets $344,178,000 | EPS -$0.33 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/13/2021 6:12:57 AM | Small | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Rev: $113,000 -28.0% | Assets $355,910,000 | EPS -$0.29 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 8/13/2021 6:07:28 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev $113,000 -28.0% | Assets $355,910,000 | EPS -$0.29 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/14/2021 8:11:21 AM | Small | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Rev: $128,000 -68.5% | Assets $354,393,000 | EPS -$0.26 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 5/14/2021 8:01:00 AM | View | Financials | Earnings | SEC | 1Q 2021 | Rev $128,000 -68.5% | Assets $354,393,000 | EPS -$0.26 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 4/23/2021 8:32:05 AM | View | Proxy | SEC | Y 2020 | ||||||
| PMV Pharmaceuticals, Inc. (PMVP) | 3/3/2021 4:23:31 PM | Small | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | Rev: $651,000 -50.0% | Assets $365,531,000 | EPS -$2.40 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 3/3/2021 4:16:39 PM | View | Financials | Earnings | SEC | Y 2020 | Rev $48,000 -84.8% | Assets $365,531,000 | EPS $3.53 | Export Earnings Model | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/13/2020 5:16:46 PM | Small | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 | Rev: $40,000 -85.3% | Assets $374,446,000 | EPS -$1.46 | |
| PMV Pharmaceuticals, Inc. (PMVP) | 11/13/2020 8:27:14 AM | View | Earnings | SEC | 3Q 2020 | Rev $40,000 -85.3% | Assets $374,446,000 | EPS -$1.46 |